Published in Pain and Central Nervous System Week, December 25th, 2006
Conducted by researchers at the Pain Management Research Institute in Sydney, Australia, the study is the largest controlled clinical trial ever of patients with spinal cord injury who suffer from central neuropathic pain, a particularly persistent and severe pain condition.
Results from the study showed that patients using pregabalin (150-600 mg/day) experienced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.